Chart of the Week: Pharma Trials Using Selection Biomarkers

Sep 19, 2016 | Biomarkers, News

In BiomarkerBase we track biomarker use in trials, including those biomarkers used as patient selection criteria in particular clinical trials. We used this capability in a report we recently co-authored with BIO and Informa on clinical trials success rates (spoiler:...

Chart of the Week: 3x Improvement in Likelihood of Approval

Sep 12, 2016 | News

In May we released a report co-authored with BIO and BioMedTracker. One of the key take-aways from the report is that patient selection biomarkers, if used successfully, can triple the Likelihood of Approval (LOA) for clinical studies.  Here is the data: Share this...

Chart of the Week: Liquid Biopsy Focused on Lung Cancer

Aug 30, 2016 | News

Last week we did a follow-up webinar on liquid biopsy.  In the extended analysis it became apparent that lung cancer is the focus of liquid biopsy. While breast cancer shows up on the top of this list, the combination of NSCLC and lung cancer surpasses breast cancer...

Chart of the Week: Cost of Biomarker Information

Aug 26, 2016 | Biomarkers, News

It is more costly to get biomarker information from public sources than you think. The volume of information requires technology assistance to be efficient. AI approaches like Natural Language Processing (NLP) are the best bet for efficient gathering of clinical...

Chart of the Week: Rare Disease Activity Sample (LSDs)

Jul 27, 2016 | News

We have recently noticed a trend among our customers. We have been successfully addressing some key use cases of our customers focused on rare and orphan diseases. This is an interesting coincidence since rare diseases played such a key role in our recently published...